SCHEMBL11818315

SCHEMBL11818315

CCCCNS(=O)(=O)c1cc(SCc2cccc(Cl)c2)cc(C(=O)O)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 6/20 0.54
▸ LMNA P02545 1/20 0.46
▸ MAPT P10636 1/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ FABP4 P15090 2/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ CA12 O43570 3/20 0.40
▸ CA9 Q16790 3/20 0.40
▸ AR P10275 1/20 0.40
▸ MRGPRX4 Q96LA9 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA6 P23280 1/20 0.40
▸ CA5A P35218 1/20 0.40
▸ CA7 P43166 1/20 0.40
▸ CA13 Q8N1Q1 1/20 0.40
▸ CA14 Q9ULX7 1/20 0.40
▸ CA5B Q9Y2D0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11814852 0.78 AKR1C3 (0.48) AKR1C3LMNAMAPTALDH1A1CA12
SCHEMBL11826895 0.77 PTPRC (0.46) AKR1C3LMNAMAPTMEN1KMT2A
SCHEMBL11820641 0.75 AKR1C3 (0.52) AKR1C3LMNAMAPTCA12CA9
SCHEMBL11822234 0.74 L3MBTL1 (0.57) LMNAMAPTMEN1ALDH1A1KMT2A
SCHEMBL13802466 0.72 MRGPRX4 (0.63) AKR1C3MAPTARMRGPRX4PTPRC
SCHEMBL11815605 0.72 CA12 (0.46) MAPTMEN1ALDH1A1KMT2ACA12
SCHEMBL11816193 0.71 KMT2A (0.44) MAPTMEN1KMT2ACA12CA9
SCHEMBL693069 0.71 RXRA (0.57) LMNAMAPTMEN1KMT2AAR
SCHEMBL11827713 0.70 KMT2A (0.43) MEN1KMT2ACYP2C19CA12CA9
SCHEMBL31014170 0.69 LMNA (0.56) LMNAMEN1ALDH1A1KMT2ACYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954994-A Intermediates for preparing hipolipemic agents and method of lowering the blood lipid level in mammals with said agents PFIZER INC. (US) 1976-05-04 — — US disclosed
Send feedback